Merck & Co. is caught in the middle of Wall Street's version of a group chat disagreement. Analysts gave it a “Moderate Buy” ...

UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

Amazon has responded to tariff concerns by leaning on its third-party sellers, who bulked up inventory to maintain pricing ...

Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

Nebula Research & Development LLC more than doubled its Chevron holdings in Q4, snapping up 5,165 additional shares worth ...

Perbak Capital Partners just dove into Danaher with a tidy $1.1 million buy of 4,911 shares, joining a growing bandwagon of ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

Alphabet, despite a tech giant glow-up, has underperformed the broader market, dropping 16.1% year-to-date while others ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

AMD is preparing to report its Q1 2025 earnings with strong expectations: $0.94 EPS and $7.12 billion in revenue. Analyst Jay ...

Mission Creek Capital Partners Inc. jumped into the financial fray by acquiring 21,444 shares of Bank of America, a stake ...